263 related articles for article (PubMed ID: 17275988)
1. Rebuttal from authors re: Edward M. Messing. Node positive renal cell cancer. Who can be helped? Eur Urol 2007;51:1477-8.
Karakiewicz P; Perrotte P; Trinh QD; Patard JJ
Eur Urol; 2007 Jun; 51(6):1478-80. PubMed ID: 17275988
[No Abstract] [Full Text] [Related]
2. Node positive renal cell cancer. Who can be helped?
Messing EM
Eur Urol; 2007 Jun; 51(6):1477-8. PubMed ID: 17240037
[No Abstract] [Full Text] [Related]
3. High-dose interleukin-2 in metastatic renal cell carcinoma.
Fernández-Rodríguez R; de Argumedo GL; Mañé JM; Muñoz A; Ferreiro J; Fuente N; López-Vivanco G
J Clin Oncol; 2005 Sep; 23(27):6797-8; author reply 6798-9. PubMed ID: 16170190
[No Abstract] [Full Text] [Related]
4. Rebuttal from authors re: Vincenzo Ficarra, Antonio Galfano and Stefano Cavalleri. Is simple enucleation a minimal partial nephrectomy responding to the EAU guidelines' recommendations? Eur Urol 2009;55:1315-8.
Minervini A; Serni S; Di Cristofano C; Carini M
Eur Urol; 2009 Jun; 55(6):1319-20. PubMed ID: 18804906
[No Abstract] [Full Text] [Related]
5. Current clinical trials in renal cell carcinoma.
Sokoloff MH; Daneshmand S; Ryan CW
Urol Oncol; 2005; 23(4):289-92. PubMed ID: 16018946
[TBL] [Abstract][Full Text] [Related]
6. Re: Puppo P, Introini C, Calvi P, Naselli A. Long term results of excision of small renal cancer surrounded by a minimal layer of grossly normal parenchyma: review of 94 cases. Eur Urol 2004;46:477-81.
Carini M; Lapini A; Minervini A; Serni S
Eur Urol; 2005 Feb; 47(2):265-6; author reply 266. PubMed ID: 15661426
[No Abstract] [Full Text] [Related]
7. Re: Steiner T, Knels R, Schubert J. Prognostic significance of tumor size in patients after tumour nephrectomy for localised renal cell carcinoma. Eur Urol 46;2004:327-30.
Bogdanovic J
Eur Urol; 2005 Feb; 47(2):266-7. PubMed ID: 15661427
[No Abstract] [Full Text] [Related]
8. Current status of cytoreductive nephrectomy in metastatic renal cell carcinoma.
Harshman LC; Srinivas S
Expert Rev Anticancer Ther; 2007 Dec; 7(12):1749-61. PubMed ID: 18062749
[TBL] [Abstract][Full Text] [Related]
9. Re: Ziya Kirkali and Hein van Poppel. A critical analysis of surgery for kidney cancer with vena cava invasion. Eur Urol 2007;52:658-62.
Labanaris AP; Kühn R; Schott GE; Zugor V
Eur Urol; 2007 Dec; 52(6):1800-1; author reply 1801-2. PubMed ID: 17888565
[No Abstract] [Full Text] [Related]
10. Predicting cancer-control outcomes in patients with renal cell carcinoma.
Karakiewicz PI; Hutterer GC
Curr Opin Urol; 2007 Sep; 17(5):295-302. PubMed ID: 17762620
[TBL] [Abstract][Full Text] [Related]
11. The role of cytoreductive nephrectomy in the era of molecular targeted therapy.
Polcari AJ; Gorbonos A; Milner JE; Flanigan RC
Int J Urol; 2009 Mar; 16(3):227-33. PubMed ID: 19207114
[TBL] [Abstract][Full Text] [Related]
12. Prognostic factors for renal cell carcinoma with tumor thrombus extension.
Klatte T; Pantuck AJ; Riggs SB; Kleid MD; Shuch B; Zomorodian N; Kabbinavar FF; Belldegrun AS
J Urol; 2007 Oct; 178(4 Pt 1):1189-95; discussion 1195. PubMed ID: 17698087
[TBL] [Abstract][Full Text] [Related]
13. Re: Mesut Remzi, Michael Marberger. Renal tumor biopsies for evaluation of small renal tumors: why, in whom, and how? Eur urol 2009;55:359-67.
Park BK
Eur Urol; 2009 Jun; 55(6):e99-100; author reply e101-2. PubMed ID: 19286305
[No Abstract] [Full Text] [Related]
14. Are we really making an advance in the treatment of metastatic renal cell carcinoma?
Kirkali Z
Eur Urol; 2006 Apr; 49(4):604-5. PubMed ID: 16481098
[No Abstract] [Full Text] [Related]
15. Re: outcome of stage T2 or greater renal cell cancer treated with partial nephrectomy: R. H. Breau, P. L. Crispen, R. E. Jimenez, C. M. Lohse, M. L. Blute and B. C. Leibovich J Urol 2010; 183: 903-908.
Cimen HI; Canda AE; Balbay MD
J Urol; 2010 Nov; 184(5):2212; author reply 2212-3. PubMed ID: 20864129
[No Abstract] [Full Text] [Related]
16. Renal cell carcinoma: vena caval involvement.
Boorjian SA; Sengupta S; Blute ML
BJU Int; 2007 May; 99(5 Pt B):1239-44. PubMed ID: 17441917
[No Abstract] [Full Text] [Related]
17. The role of pathology for clinical decision-making in renal cell carcinoma is increasing.
Terrone C; Volpe A
Eur Urol; 2007 May; 51(5):1166-8; discussion 1168-70. PubMed ID: 17257741
[No Abstract] [Full Text] [Related]
18. Predictors of oncological outcome after resection of locally recurrent renal cell carcinoma.
Margulis V; McDonald M; Tamboli P; Swanson DA; Wood CG
J Urol; 2009 May; 181(5):2044-51. PubMed ID: 19286220
[TBL] [Abstract][Full Text] [Related]
19. Editorial comment.
Uzzo RG
J Urol; 2009 Nov; 182(5):2171. PubMed ID: 19758642
[No Abstract] [Full Text] [Related]
20. Lymph node dissection is not obsolete in clinically node-negative renal cell carcinoma patients.
Van Poppel H
Eur Urol; 2011 Jan; 59(1):24-5. PubMed ID: 20943309
[No Abstract] [Full Text] [Related]
[Next] [New Search]
